Pulmonary Arterial Hypertension (PAH) Clinical Trial
Official title:
A Non-interventional Study to Further Characterize the Safety and Effectiveness of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China in a Real World Setting
This observational study will involve analysis of data collected by the National Rare Disease Registry or medical records .The study will describe outcomes only in PAH(Pulmonary arterial hypertension) patients treated with sildenafil; there will be no comparison with another treatment group. Approximately 100 adults with PAH will be recruited in China hospitals This NIS(non-interventional study) data will be recorded by a physician in the medical records, during the patients' clinical visits, and in the electronic Case Report Forms (CRF).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03145298 -
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy
|
Phase 1 | |
| Recruiting |
NCT03362047 -
(RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment)
|
Phase 2 | |
| Recruiting |
NCT03235401 -
The PAH Disability and Bothersomeness Questionnaire
|
N/A | |
| Not yet recruiting |
NCT05947240 -
Effects of UE Aerobic Exercise on Exercise Capacity and PA in Patients With Pulmonary Arterial Hypertension.
|
N/A | |
| Recruiting |
NCT01347216 -
COMPERA / COMPERA-KIDS
|
||
| Terminated |
NCT00586794 -
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
|
Phase 3 | |
| Completed |
NCT03523910 -
Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension
|
N/A |